Cargando…
Precipitating hydrophobic injectable liquid (PHIL) embolic for the treatment of a uterine arteriovenous malformation: a technical report
OBJECTIVE: Uterine arteriovenous malformations (AVM) are unusual causes of vaginal bleeding. Although hysterectomy is the definitive treatment; uterine artery embolization (UAE) provides an alternative therapeutic option. This case presents a technical report of a uterine AVM treated successfully wi...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7224241/ https://www.ncbi.nlm.nih.gov/pubmed/32026176 http://dx.doi.org/10.1186/s42155-019-0059-z |
_version_ | 1783533864587624448 |
---|---|
author | Kurda, Dylan Guduguntla, Geetha Maingard, Julian Kok, Hong Kuan Lalloo, Shivendra |
author_facet | Kurda, Dylan Guduguntla, Geetha Maingard, Julian Kok, Hong Kuan Lalloo, Shivendra |
author_sort | Kurda, Dylan |
collection | PubMed |
description | OBJECTIVE: Uterine arteriovenous malformations (AVM) are unusual causes of vaginal bleeding. Although hysterectomy is the definitive treatment; uterine artery embolization (UAE) provides an alternative therapeutic option. This case presents a technical report of a uterine AVM treated successfully with transcatheter UAE using precipitating hydrophobic injectable liquid (PHIL) embolic agent. CASE REPORT: A 41-year-old female, gravida 6, para 4, miscarriage 2, including a molar pregnancy 15 years prior, presented with massive per vaginal bleeding. Pelvic ultrasound demonstrated an acquired AVM as the underlying aetiology for her presentation. The patient underwent bilateral uterine arterial embolization. Four weeks later, there was nearly complete resolution of the AVM and the patient’s menstrual cycle was restored 8 weeks after the procedure. CONCLUSION: Uterine AVM can be treated safely and effectively with UAE using PHIL. |
format | Online Article Text |
id | pubmed-7224241 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-72242412020-05-15 Precipitating hydrophobic injectable liquid (PHIL) embolic for the treatment of a uterine arteriovenous malformation: a technical report Kurda, Dylan Guduguntla, Geetha Maingard, Julian Kok, Hong Kuan Lalloo, Shivendra CVIR Endovasc Case Report OBJECTIVE: Uterine arteriovenous malformations (AVM) are unusual causes of vaginal bleeding. Although hysterectomy is the definitive treatment; uterine artery embolization (UAE) provides an alternative therapeutic option. This case presents a technical report of a uterine AVM treated successfully with transcatheter UAE using precipitating hydrophobic injectable liquid (PHIL) embolic agent. CASE REPORT: A 41-year-old female, gravida 6, para 4, miscarriage 2, including a molar pregnancy 15 years prior, presented with massive per vaginal bleeding. Pelvic ultrasound demonstrated an acquired AVM as the underlying aetiology for her presentation. The patient underwent bilateral uterine arterial embolization. Four weeks later, there was nearly complete resolution of the AVM and the patient’s menstrual cycle was restored 8 weeks after the procedure. CONCLUSION: Uterine AVM can be treated safely and effectively with UAE using PHIL. Springer International Publishing 2019-05-17 /pmc/articles/PMC7224241/ /pubmed/32026176 http://dx.doi.org/10.1186/s42155-019-0059-z Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Case Report Kurda, Dylan Guduguntla, Geetha Maingard, Julian Kok, Hong Kuan Lalloo, Shivendra Precipitating hydrophobic injectable liquid (PHIL) embolic for the treatment of a uterine arteriovenous malformation: a technical report |
title | Precipitating hydrophobic injectable liquid (PHIL) embolic for the treatment of a uterine arteriovenous malformation: a technical report |
title_full | Precipitating hydrophobic injectable liquid (PHIL) embolic for the treatment of a uterine arteriovenous malformation: a technical report |
title_fullStr | Precipitating hydrophobic injectable liquid (PHIL) embolic for the treatment of a uterine arteriovenous malformation: a technical report |
title_full_unstemmed | Precipitating hydrophobic injectable liquid (PHIL) embolic for the treatment of a uterine arteriovenous malformation: a technical report |
title_short | Precipitating hydrophobic injectable liquid (PHIL) embolic for the treatment of a uterine arteriovenous malformation: a technical report |
title_sort | precipitating hydrophobic injectable liquid (phil) embolic for the treatment of a uterine arteriovenous malformation: a technical report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7224241/ https://www.ncbi.nlm.nih.gov/pubmed/32026176 http://dx.doi.org/10.1186/s42155-019-0059-z |
work_keys_str_mv | AT kurdadylan precipitatinghydrophobicinjectableliquidphilembolicforthetreatmentofauterinearteriovenousmalformationatechnicalreport AT guduguntlageetha precipitatinghydrophobicinjectableliquidphilembolicforthetreatmentofauterinearteriovenousmalformationatechnicalreport AT maingardjulian precipitatinghydrophobicinjectableliquidphilembolicforthetreatmentofauterinearteriovenousmalformationatechnicalreport AT kokhongkuan precipitatinghydrophobicinjectableliquidphilembolicforthetreatmentofauterinearteriovenousmalformationatechnicalreport AT lallooshivendra precipitatinghydrophobicinjectableliquidphilembolicforthetreatmentofauterinearteriovenousmalformationatechnicalreport |